Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Vero Cell-Derived vs Egg-Derived Influenza Vaccine
NCT00289510Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Jan 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Fluzone Trivalent in influenza, sponsored by Resilience Government Services. Started Jan 2006; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00289510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289510.